The Competition Commission, in its meeting on 29.08.2024, reviewed four concentration notifications: The concentration obtained through the acquisition of control of Cura Domo Holding GmbH by Mavie Next GmbH. The proposed concentration obtained through the acquisition of joint control of Immedica Pharma Holding AB by KKR and Impilo No 4